Showing results (211-220 of 309) with videos related to
Sort By:
Pageof 31
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.Indian Journal of Cancer|January 21, 2011
Outcome of combined modality treatment including neoadjuvant chemotherapy of 128 cases of locally advanced breast cancer: data from a tertiary cancer center in northern IndiaV Raina, M Kunjahari, N K Shukla, et al.The Malaysian Journal of Pathology|April 20, 2015
Role of directional vacuum assisted breast biopsy in previously equivocal biopsies for breast masses suspicious for malignancyU Debi, S Thulkar, S Sharma, et al.The Journal of the Association of Physicians of India|July 4, 2003
Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemmaS V S Deo, J Purkayastha, N K Shukla, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 6, 2015
Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patientsN Iqbal, N K Shukla, S V S Deo, et al.European Journal of Biochemistry|January 2, 1984
Study of the Zn-containing DD-carboxypeptidase of Streptomyces albus G by small-angle X-ray scattering in solutionH Labischinski, P Giesbrecht, E Fischer, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 17, 2014
Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North IndiaShilpi Chattopadhyay, Sarah Siddiqui, Md Salman Akhtar, et al.Journal of Cancer Research and Therapeutics|April 3, 2023
PD-L1 expression in rare and aggressive thyroid cancers: A preliminary investigation for a role of immunotherapyMonikongkona Boruah, Pranitha Gaddam, Shipra Agarwal, et al.Plos One|October 22, 2014
A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North IndiaSarah Siddiqui, Shilpi Chattopadhyay, Md Salman Akhtar, et al.Tumori|December 24, 2013
Perioperative high-dose-rate interstitial brachytherapy boost for patients with early breast cancerDaya Nand Sharma, S V S Deo, Goura Kisor Rath, et al.Pageof 31